Metagenomics, which uses genomic analysis to study microbial genomes from environmental samples, has transformed our understanding of microbial diversity and functionality. The market's growth is fueled by advancements in sequencing technologies, awareness of microbial health impacts, and applications in agriculture, biotechnology, and environmental restoration. Additionally, the rising demand for personalized medicine and the search for new antibiotics and enzymes are driving the market, highlighting metagenomics' crucial role in scientific research and commercial uses.
The global metagenomics market, valued at $1,808.0 million in 2023, is projected to reach $9,286.1 million by 2033, growing at a CAGR of 17.90% from 2024 to 2033. This significant growth is driven by the exploration of microbial communities that cannot be cultured in the lab.
The global metagenomics market is expanding rapidly due to advancements in genetic sequencing and growing awareness of microbes' health and environmental impacts. By decoding genetic material from microbial communities without traditional culturing, metagenomics drives improved diagnostics, bioremediation, and sustainable agricultural practices. This market, vital for healthcare, sustainability, and bio innovation, is segmented by product type, workflow, application, technology, and region.
• Consumables
• Instruments
• Services and Software
• Sample Preparation (Pre-Sequencing)
• Sequencing
• Data Analysis
• Capillary Electrophoresis
• Single Molecule Sequencing
• Sequencing by Synthesis
• Sequencing by Ligation
• Nanopore Sequencing
• Other Technologies
• Clinical Diagnostics
• Industrial Applications
• Research Applications
• North America
o U.S.
o Canada
• Europe
o Germany
o U.K.
o France
o Italy
o Spain
o Rest-of-Europe
• Asia-Pacific
o Japan
o India
o China
o South Korea
o Australia
o Rest-of-Asia-Pacific
• Latin America
o Brazil
o Mexico
o Rest-of-Latin America
• Middle East and Africa
o South Africa
o U.A.E.
o Rest-of-Middle East and Africa
North America is set to dominate the global metagenomics market due to its strong R&D infrastructure, substantial biotech and life sciences investments, and a concentration of leading biotech and pharmaceutical companies. Increased awareness of microbial communities' roles in health and the environment, along with boosted research funding, further accelerates market growth in the region.
• January 2024: Eurofins Genomics opened a certified sequencing lab in Bothell, Washington, utilizing the Oxford Nanopore platform for rapid 12-hour results, partnering with 30 Seattle labs.
• February 2024: MGI Tech Co., Ltd. partnered with MetaGenoPolis of France's National Research Institute for Agriculture, Food and the Environment, following its selection for the Million Microbiomes from Humans Project.
• June 2023: Eurofins Genomics U.S. launched an express Oxford Nanopore sequencing service for same-day results.
• March 2023: Macrogen Inc. introduced the NovaSeq X Plus system to Korea, its first entry into the Asian market.
• Reduction in Sequencing Costs
• Technological Advancements
• Data Storage Security
• Data Management and Analysis
• Discovery of Microbial Solutions
• Enhanced Environmental Sustainability
• BGI Genomics
• Eurofins Scientific
• Illumina, Inc.
• MGI Tech Co., Ltd.
• Oxford Nanopore Technologies plc
• Pacific Biosciences of California, Inc.
• Macrogen, Inc.
• QIAGEN N.V.
• Revvity, Inc. (PerkinElmer Inc.)
• Thermo Fisher Scientific, Inc.
Discover your success with BIS Research’s Go-to-Market Strategy customized approach crafted to drive your business into emerging markets. Unlock new opportunities with our professional guidance today.
